Heron Therapeutics, Inc., incorporated on February 5, 1987, is a biotechnology company. The Company is engaged in developing pharmaceutical products for patients suffering from cancer or pain. The Company's product candidates include SUSTOL, HTX-019 and HTX-011. All of its product candidates utilize science and technology platforms, including its Biochronomer drug delivery technology (Biochronomer technology), which can deliver therapeutic levels of a range of otherwise short-acting pharmacological agents over a period of days to weeks with a single subcutaneous injection.
4242 Campus Point Ct Ste 200
The company trades on NASDAQ exchange. The company headquarter is located in California, CA. The company was established in the 1983.| Ticker | HRTX |
| Long Name | Heron Therapeutics, Inc. |
| Short Name | Heron Therapeutics |